Search Results 661-670 of 18065 for Alopecia
Recovery to Grade 1 or baseline of any non-hematologic toxicities due to prior treatments, excluding alopecia and Grade 2 neuropathy. Subject must ...
... alopecia, anemia and any signs or symptoms of androgen deprivation therapy); Willing to provide tissue and blood samples for correlative research purposes ...
In this group of inherited disorders, the body makes little or no melanin, a pigment that determines hair, skin and eye color and vision development.
... alopecia, fatigue, and hematologic toxicities); Have a known immediate or delayed hypersensitivity reaction or idiosyncrasy to drugs chemically related to ...
Any unresolved toxicity NCI CTCAE Grade ≥2 from previous anticancer therapy with the exception of alopecia, vitiligo, and the laboratory values defined in the ...
03) except for alopecia, Grade 2 sensory neurotoxicity, or any other toxicity that in the opinion of the Investigator does not affect the assessment of ...
... alopecia; Radiation therapy within ≤ 14 days; Active or untreated brain metastases; History of carcinomatous meningitis; Uncontrolled concurrent malignancy ...
... alopecia or peripheral neuropathy AND have a washout period from last dose of prior systemic or radiation therapy as follows: Patients must discontinue ...
− Have any other unresolved chronic toxicity with CTCAE Grade ≥ 2, except hair changes (such as alopecia or high lightening). Participants who have ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.